Reading focus
Syllabus: How Does Substance Use Become Persistent Despite Harm?
Trace what was manipulated in the laboratory and what was subsequently observed after discharge.
Why you’re reading it. Examine evidence connecting stress-related responses with course without turning prediction into causation.
A question to consider. How would the design need to change to test whether reducing the measured response improves later outcomes?
Why this reading
A laboratory response and a later clinical outcome are different forms of evidence. Sinha and colleagues combine controlled imagery conditions with follow-up after inpatient treatment. The design lets readers distinguish an induced short-term response from a marker that predicts what happens later.
Before you read
The hypothalamic–pituitary–adrenal axis coordinates hormonal responses to stress. Corticotropin and cortisol are measured here, with their ratio used as an index of adrenal sensitivity. A hazard ratio compares rates of an event over follow-up; it is not the probability that an individual will experience it.
Read for
- Separate the matched group comparison from the prospective follow-up and identify which conditions were experimentally varied.
- Compare craving, anxiety and hormonal measures. Do their associations with return to any drinking and heavy drinking agree?
- Examine follow-up coverage, self-report and covariate selection before interpreting a proposed clinical marker.
Consider afterwards
- Would predicting return to drinking establish that lowering the predictor would prevent it? Specify the additional test.
- Why might a measure predict one definition of relapse but not another?
Editorial context
The follow-up concerned 93 treatment-engaged, medication-free inpatients after about a month of abstinence. It cannot represent every person with alcohol difficulties. Imagery order was randomized; later relapse and treatment participation were observed. The study therefore does not establish that manipulating a hormone would change recovery, and the authors make clinical-marker use conditional on further validation.